These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy. Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362 [TBL] [Abstract][Full Text] [Related]
23. Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease. Agarwal P; Cole LK; Chandrakumar A; Hauff KD; Ravandi A; Dolinsky VW; Hatch GM Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002286 [TBL] [Abstract][Full Text] [Related]
24. Characterization of lymphoblast mitochondria from patients with Barth syndrome. Xu Y; Sutachan JJ; Plesken H; Kelley RI; Schlame M Lab Invest; 2005 Jun; 85(6):823-30. PubMed ID: 15806137 [TBL] [Abstract][Full Text] [Related]
25. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome. Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983 [TBL] [Abstract][Full Text] [Related]
26. The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin-deficient cells. Oemer G; Koch J; Wohlfarter Y; Lackner K; Gebert REM; Geley S; Zschocke J; Keller MA J Inherit Metab Dis; 2022 Jan; 45(1):38-50. PubMed ID: 34494285 [TBL] [Abstract][Full Text] [Related]
28. Phospholipid abnormalities in children with Barth syndrome. Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265 [TBL] [Abstract][Full Text] [Related]
29. Cardiac metabolic pathways affected in the mouse model of barth syndrome. Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409 [TBL] [Abstract][Full Text] [Related]
30. Cardiolipin deficiency leads to the destabilization of mitochondrial magnesium channel MRS2 in Barth syndrome. Joshi A; Gohil VM Hum Mol Genet; 2023 Dec; 32(24):3353-3360. PubMed ID: 37721533 [TBL] [Abstract][Full Text] [Related]
31. Interplay between cardiolipin and plasmalogens in Barth syndrome. Bozelli JC; Epand RM J Inherit Metab Dis; 2022 Jan; 45(1):99-110. PubMed ID: 34655242 [TBL] [Abstract][Full Text] [Related]
32. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype. Bowron A; Honeychurch J; Williams M; Tsai-Goodman B; Clayton N; Jones L; Shortland GJ; Qureshi SA; Heales SJ; Steward CG J Inherit Metab Dis; 2015 Mar; 38(2):279-86. PubMed ID: 25112388 [TBL] [Abstract][Full Text] [Related]
33. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome. Gaspard GJ; McMaster CR Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690 [TBL] [Abstract][Full Text] [Related]
35. Decreased pyruvate dehydrogenase activity in Tafazzin-deficient cells is caused by dysregulation of pyruvate dehydrogenase phosphatase 1 (PDP1). Liang Z; Ralph-Epps T; Schmidtke MW; Kumar V; Greenberg ML J Biol Chem; 2024 Mar; 300(3):105697. PubMed ID: 38301889 [TBL] [Abstract][Full Text] [Related]
36. When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription. Ferri L; Dionisi-Vici C; Taurisano R; Vaz FM; Guerrini R; Morrone A Clin Genet; 2016 Nov; 90(5):461-465. PubMed ID: 26853223 [TBL] [Abstract][Full Text] [Related]
37. Cardiolipin function in the yeast S. cerevisiae and the lessons learned for Barth syndrome. Ji J; Greenberg ML J Inherit Metab Dis; 2022 Jan; 45(1):60-71. PubMed ID: 34626131 [TBL] [Abstract][Full Text] [Related]
38. An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio. Vaz FM; van Lenthe H; Vervaart MAT; Stet FS; Klinkspoor JH; Vernon HJ; Goorden SMI; Houtkooper RH; Kulik W; Wanders RJA J Inherit Metab Dis; 2022 Jan; 45(1):29-37. PubMed ID: 34382226 [TBL] [Abstract][Full Text] [Related]
39. Identification of novel mitochondrial localization signals in human Tafazzin, the cause of the inherited cardiomyopathic disorder Barth syndrome. Dinca AA; Chien WM; Chin MT J Mol Cell Cardiol; 2018 Jan; 114():83-92. PubMed ID: 29129703 [TBL] [Abstract][Full Text] [Related]
40. Cardiolipin-deficient cells have decreased levels of the iron-sulfur biogenesis protein frataxin. Li Y; Lou W; Grevel A; Böttinger L; Liang Z; Ji J; Patil VA; Liu J; Ye C; Hüttemann M; Becker T; Greenberg ML J Biol Chem; 2020 Aug; 295(33):11928-11937. PubMed ID: 32636300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]